|Project Title||Pharmacogenetic Testing|
This project contains three reports. Report 1 (Project ID: CDER_MPL1R_WP021_NSDP_V01) contains estimates of drug use among patients with a prior genetic test and/or relevant cancer diagnosis. Report 2 (Project ID: CDER_MPL1R_WP022_NSDP_V02) contains estimated distribution of baseline covariates among members receiving various genetic tests: KRAS, BRAF, EGFR, BCR-ABL, and BRCA. Report 3 (Project ID: CDER_MPL1R_WP031_NSDP_V01) contains estimates of drug initiation following genetic testing among patients with relevant cancers.
Thursday, May 11, 2017
Modular Programs and Summary Tables